Suppr超能文献

抗精神病药物治疗依从性不佳对精神障碍患者再次住院的影响。

The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders.

作者信息

Abdullah-Koolmees H, Nawzad S, Egberts T C G, Vuyk J, Gardarsdottir H, Heerdink E R

机构信息

Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Postbus 85500, Utrecht 3508 GA, The Netherlands.

Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Ther Adv Psychopharmacol. 2021 Jun 25;11:20451253211027449. doi: 10.1177/20451253211027449. eCollection 2021.

Abstract

BACKGROUND AND AIMS

Many patients with psychotic disorders are non-adherent to antipsychotic (AP) medication(s), potentially contributing to rehospitalization. It is unknown whether non-adherence in different phases of AP use is associated with rehospitalization. The aim of this study was to assess the association between non-adherence to APs and rehospitalization in patients with psychotic disorders. Non-adherence was assessed specifically for the initiation, continued drug use and early discontinuation of AP use.

METHODS

A retrospective follow-up study was performed. Adult patients were included at discharge if they suffered from schizophrenia, psychotic, or bipolar I disorder; had been hospitalized in a psychiatric hospital for ⩾7 days; and were treated with oral APs. Patients discharged between January 2006 and December 2009 from Altrecht Mental Health Care were included. Non-adherence was studied in the three phases of medication use: initiation, continued drug use (implementation) and (early) discontinuation after discharge until the end of follow up or until patients were rehospitalized. Cox regression analysis was used to assess the strength of the association between non-adherence for the different phases of AP use and rehospitalization during follow up and expressed as relative risk (RR) with 95% confidence intervals (CI).

RESULTS

A total of 417 patients were included. Patients who did not initiate their APs compared with those who did in the first month (RR = 1.62, 95% CI: 1.19-2.19) and between the first and third month after discharge (RR = 1.70, 95% CI: 1.04-2.79) had the highest risk for rehospitalization during follow up. Overall, patients who did not initiate their AP medication within the first year after discharge had a RR of 2.70 (95% CI: 1.97-3.68) for rehospitalization during follow up compared with those that initiated their AP.

CONCLUSION

Not initiating APs right after discharge was associated with an increased risk of rehospitalization. Interventions should aim to promote the initiation of APs soon after discharge to minimize the risk of rehospitalization.

摘要

背景与目的

许多精神病患者不坚持服用抗精神病药物,这可能导致再次住院。目前尚不清楚在抗精神病药物使用的不同阶段不坚持服药是否与再次住院有关。本研究的目的是评估精神病患者不坚持服用抗精神病药物与再次住院之间的关联。具体评估了抗精神病药物使用的起始阶段、持续用药阶段和早期停药阶段的不依从情况。

方法

进行了一项回顾性随访研究。纳入的成年患者出院时患有精神分裂症、精神病性障碍或双相I型障碍;曾在精神病医院住院至少7天;并接受口服抗精神病药物治疗。纳入了2006年1月至2009年12月期间从阿尔特赖特精神卫生保健中心出院的患者。研究了药物使用三个阶段的不依从情况:起始阶段、持续用药(实施)阶段以及出院后(早期)停药阶段直至随访结束或患者再次住院。采用Cox回归分析评估抗精神病药物使用不同阶段的不依从与随访期间再次住院之间关联的强度,并以相对风险(RR)及95%置信区间(CI)表示。

结果

共纳入417例患者。与出院后第一个月开始服用抗精神病药物的患者相比,未在第一个月开始服药的患者(RR = 1.62,95%CI:1.19 - 2.19)以及出院后第一个月至第三个月开始服药的患者(RR = 1.70,95%CI:1.04 - 2.79)在随访期间再次住院的风险最高。总体而言,出院后第一年内未开始服用抗精神病药物的患者与开始服用抗精神病药物的患者相比,随访期间再次住院的RR为2.70(95%CI:1.97 - 3.68)。

结论

出院后未立即开始服用抗精神病药物与再次住院风险增加有关。干预措施应旨在促进出院后尽快开始服用抗精神病药物,以将再次住院风险降至最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/8246479/1278fb468fcd/10.1177_20451253211027449-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验